Literature DB >> 14992592

Acid-induced unfolding mechanism of recombinant human endostatin.

Bing Li1, Xiaoyu Wu, Hao Zhou, Qianjie Chen, Yongzhang Luo.   

Abstract

Endostatin is a potent angiogenesis inhibitor. The structure of endostatin is unique in that its secondary structure is mainly irregular loops and beta-sheets and contains only a small fraction of alpha-helices with two pairs of disulfide bonds in a nested pattern. We choose human endostatin as a model system to study the folding mechanism of this kind. Nuclear magnetic resonance (NMR), tryptophan emission fluorescence, and circular dichroism (CD) were used to monitor the unfolding process of endostatin upon acid titration. Urea-induced unfolding was used to measure the stability of endostatin under different conditions. Our results show that endostatin is very acid-resistant; some native structure still remains even at pH 2 as evidenced by (1)H NMR. Trifluoroethanol (TFE) destabilizes native endostatin, while it makes endostatin even more acid-resistant in the low pH region. Stability measurement of endostatin suggests that endostatin is still in native structure at pH 3.5 despite the decreased stability. Acid-induced unfolding of endostatin is reversible, although it requires a long time to reach equilibrium below pH 3. Surprisingly, the alpha-helical content of endostatin is increased when it is unfolded at pH 1.6, and the alpha-helical content of the polypeptide chain of unfolded endostatin increases linearly with TFE concentration in the range of 0-30%. This observation indicates that the polypeptide chain of unfolded endostatin has an intrinsic alpha-helical propensity. Our discoveries may provide clues for refolding endostatin more efficiently. The acid-resistance property of endostatin may have biological significance in that it cannot be easily digested by proteases in an acidic environment such as in a lysosome in the cell.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14992592     DOI: 10.1021/bi0357863

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  5 in total

1.  Endostatin: A novel inhibitor of androgen receptor function in prostate cancer.

Authors:  Joo Hyoung Lee; Tatyana Isayeva; Matthew R Larson; Anandi Sawant; Ha-Ram Cha; Diptiman Chanda; Igor N Chesnokov; Selvarangan Ponnazhagan
Journal:  Proc Natl Acad Sci U S A       Date:  2015-01-20       Impact factor: 11.205

Review 2.  Endostatin's emerging roles in angiogenesis, lymphangiogenesis, disease, and clinical applications.

Authors:  Amit Walia; Jessica F Yang; Yu-Hui Huang; Mark I Rosenblatt; Jin-Hong Chang; Dimitri T Azar
Journal:  Biochim Biophys Acta       Date:  2015-09-12

3.  Fibrinogen facilitates the anti-tumor effect of nonnative endostatin.

Authors:  Huadong Tang; Yan Fu; Qingxin Lei; Qing Han; Victoria A Ploplis; Francis J Castellino; Ling Li; Yongzhang Luo
Journal:  Biochem Biophys Res Commun       Date:  2009-01-22       Impact factor: 3.575

4.  Plasmodium vivax tryptophan-rich antigen PvTRAg33.5 contains alpha helical structure and multidomain architecture.

Authors:  Hema Bora; Sheena Garg; Priyankar Sen; Deepak Kumar; Punit Kaur; Rizwan Hasan Khan; Yagya D Sharma
Journal:  PLoS One       Date:  2011-01-20       Impact factor: 3.240

5.  Comparisons of biophysical properties and bioactivities of mono-PEGylated endostatin and an endostatin analog.

Authors:  Shan Wang; Yan Fu; Yongzhang Luo
Journal:  Chin J Cancer       Date:  2016-01-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.